Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.

Abbott Diabetes And Cardiology Updates Test Growth Story For Investors

Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system ...
GlobalData on MSN

Abbott reports positive FREEDM2 study results for CGM

The study was carried out at 24 clinical sites across the UK and included 303 participants.

Diabetic glucose monitors recalled after 7 deaths, alarming patients

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths - Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warni ...
AOL

Seven deaths linked to malfunctioning glucose monitors

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) ...
Black Enterprise

Glucose Monitor Malfunctions Linked To 7 Deaths, Over 700 Severe Injuries

Abbott's FreeStyle Libre is a device that measures glucose levels via a sensor applied to the upper back of the arm. The Food and Drug Administration (FDA) issued a warning about malfunctioning blood ...